Immunization with Tc52 or its amino terminal domain adjuvanted with c-di-AMP induces Th17+Th1 specific immune responses and confers protection against Trypanosoma cruzi.

by Marina N Matos, Silvia I Cazorla, Kai Schulze, Thomas Ebensen, Carlos A Guzmán, Emilio L Malchiodi
Published 2017-02-01

Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine.

by Augusto E Bivona, Andrés Sánchez Alberti, Marina N Matos, Natacha Cerny, Alejandro C Cardoso, Celina Morales, Germán González, Silvia I Cazorla, Emilio L Malchiodi
Published 2018-03-01

Mucosal Heterologous Prime/Boost Vaccination Induces Polyfunctional Systemic Immunity, Improving Protection Against Trypanosoma cruzi

by Andrés Sanchez Alberti, Andrés Sanchez Alberti, Andrés Sanchez Alberti, Augusto E. Bivona, Augusto E. Bivona, Marina N. Matos, Marina N. Matos, Natacha Cerny, Natacha Cerny, Kai Schulze, Sebastian Weißmann, Thomas Ebensen, Germán González, Celina Morales, Alejandro C. Cardoso, Alejandro C. Cardoso, Silvia I. Cazorla, Silvia I. Cazorla, Carlos A. Guzmán, Emilio L. Malchiodi, Emilio L. Malchiodi
Published 2020-02-01